報價延遲最少15分鐘:2025/05/31 11:58 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.95 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-8.91/-0.12
|
|
企業價值
863.12M
|
| 資產負債 |
|
每股賬面淨值
11.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
227.04M
|
|
每股收益
5.57
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 11:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment. |